









Markets
/
Stocks
/
nasdaq-drio
/

DarioHealth Corp

DRIO

8.110USD

-0.340-4.02%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

59.76KMarket Cap

LossP/E TTM



DarioHealth Corp

8.110

-0.340-4.02%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of DarioHealth Corp

Currency: USD Updated: 2026-03-26

Key Insights

DarioHealth Corp's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 106 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.80.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

DarioHealth Corp's Score

Industry at a Glance

Industry Ranking

106 / 209

Overall Ranking

261 / 4546

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative-

DarioHealth Corp Highlights

StrengthsRisks

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Growing

The company is in a growing phase, with the latest annual income totaling USD 22.36M.

Overvalued

The company’s latest PE is -0.55, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 795.75K shares, increasing 0.01% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 99.30K shares of this stock.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

18.800

Target Price

+142.27%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-26

The current financial score of DarioHealth Corp is 5.94, ranking 180 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 5.23M, representing a year-over-year decrease of 31.21%, while its net profit experienced a year-over-year decrease of 206.10%.

Score

Industry at a Glance

Previous score

5.94

Change



Financials

8.14

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.16

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.84

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.47

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.08

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

DarioHealth Corp's Company Valuation

Currency: USD Updated: 2026-03-26

The current valuation score of DarioHealth Corp is 7.51, ranking 78 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.55, which is -95.01% below the recent high of -0.03 and -322.40% above the recent low of -2.30.

Score

Industry at a Glance

Previous score

7.51

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 106/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-26

The current earnings forecast score of DarioHealth Corp is 8.00, ranking 61 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 18.50, with a high of 25.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

18.800

Target Price

+142.27%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

DarioHealth Corp

DRIO

Medtronic PLC

MDT

Stryker Corp

SYK

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-26

The current price momentum score of DarioHealth Corp is 7.12, ranking 54 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 11.18 and the support level at 6.55, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.73

Change

0.39

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.043

Sell

RSI(14)

39.425

Neutral

STOCH(KDJ)(9,3,3)

34.712

Neutral

ATR(14)

0.809

High Vlolatility

CCI(14)

9.520

Neutral

Williams %R

66.055

Sell

TRIX(12,20)

-1.237

Sell

StochRSI(14)

78.349

Neutral

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

7.904

Buy

MA10

8.185

Sell

MA20

8.884

Sell

MA50

10.244

Sell

MA100

11.172

Sell

MA200

11.751

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-26

The current institutional shareholding score of DarioHealth Corp is 3.00, ranking 135 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 7.67%, representing a quarter-over-quarter decrease of 53.79%. The largest institutional shareholder is The Vanguard, holding a total of 99.30K shares, representing 1.47% of shares outstanding, with 67.94% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Tasso Partners, LLC

88.14K

-0.40%

Kallman (Craig)

604.80K

Nantahala Capital Management, LLC

84.61K

Solid Financial LLC

106.98K

+20.64%

The Vanguard Group, Inc.

Star Investors

18.18K

Raphael (Erez)

152.43K

+64.91%

Geode Capital Management, L.L.C.

17.92K

-1.55%

Stern (Adam K.)

34.99K

+133.44%

Franco-Yehuda (Chen)

30.00K

+20.00%

Avenue Capital Group

23.25K

Risk Assessment

Currency: USD Updated: 2026-03-26

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of DarioHealth Corp is 1.97, ranking 169 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.29. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. DarioHealth Corp’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.